Occupational Therapists in Richmond, IN Accepting Medicare

9 Occupational Therapists found. Showing 1 - 9

Ashley Mariah Haffner, BS Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3771 S A St, Richmond, IN 47374 Phone: 765-598-4197    Fax: 765-454-9759

Stephanie Pierson, OTR, DRS Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2270 Inke Rd, Richmond, IN 47374 Phone: 765-277-2998    Fax: 833-523-2388

Jeremy Ryan Vories, MSOTR Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1401 Chester Blvd, Richmond, IN 47374 Phone: 765-983-3092    Fax: 765-983-3237

Leanne E Backmeyer, MSOTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1401 Chester Blvd, Richmond, IN 47374 Phone: 765-983-3092    Fax: 765-983-3237

Mr. Thomas Patrick Murray, MOT, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1400 Highland Rd, Suite 4, Richmond, IN 47374 Phone: 765-973-8057    Fax: 765-973-8058

Mr. Richard Christopher Johnson, OTR(L) Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1401 Chester Blvd, Richmond, IN 47374 Phone: 765-983-3093

Veronica Maghielse Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2030 Chester Blvd, Richmond, IN 47374 Phone: 765-962-6546

Sharon Moore, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1400 Highland Rd, Suite 4, Richmond, IN 47374 Phone: 765-939-0820    Fax: 765-939-0920

Chanlar Seymour, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3500 Wynfield Dr, Richmond, IN 47374 Phone: 765-524-8723

News Archive

False Claims Act allegations over marketing of morphine-based drug Kadian: Alpharma to pay $42.5M

American pharmaceutical manufacturer Alpharma Inc. has agreed to pay $42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug, Kadian, the Justice Department announced today. The settlement resolves allegations that, between January 1, 2000 and December 29, 2008, Alpharma paid health care providers to induce them to promote or prescribe Kadian, and made misrepresentations about the safety and efficacy of the drug, which is used to treat chronic moderate to severe pain.

Dolbey launches DocAssist Documentation Guides for hospitals

From the Healthcare Information and Management Systems Society (HIMSS) annual conference, Dolbey introduced DocAssist Documentation Guides to help hospitals train their physicians to document patient reports according to the upcoming ICD-10 PCS requirements.

New data on Resverlogix RVX-208 for CKD treatment presented at ERA-EDTA Congress

Resverlogix Corp. today announced that new data on RVX-208 was presented at the ERA-EDTA Congress in London, England in a poster entitled: "Effects of RVX-208, a First-in-Class Epigenetic BET-Inhibitor, on Key Renal Parameters in Subjects with a History of CVD, and Chronic Kidney Disease (CKD); a Post-hoc Analysis of Patients from the ASSERT, SUSTAIN and ASSURE Clinical Trials."

Genoscience Pharma to present novel cancer therapeutic strategy at EORTC-NCI-AACR Symposium

Genoscience Pharma, a company focused on discovering and developing small molecules to treat cancer by targeting cancer stem cells, today announces that it will present data on its most promising candidate at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, in Barcelona, Spain, on November 18-21, 2014.

How RNA polymerase kick starts gene activation revealed

How 'molecular machines' inside cells swing into action to activate genes at different times in a cell's life is revealed in new research published in Molecular Cell.

Read more Medical News

› Verified 4 days ago